Real‐life effectiveness and safety of the daclatasvir/asunaprevir combination therapy for genotype 1b chronic hepatitis C patients: An emphasis on the pretreatment NS5A resistance‐associated substitution test
Keyword(s):
2013 ◽
Vol 29
(1)
◽
pp. 144-150
◽
2018 ◽
Vol 68
◽
pp. S299-S300
◽
Keyword(s):
Keyword(s):
2009 ◽
Vol 48
(5)
◽
pp. 253-258
◽
2000 ◽
Vol 75
(1-3)
◽
pp. 53-63
◽
Keyword(s):
Keyword(s):
2009 ◽
Vol 15
(3)
◽
pp. 338
◽